1382P Vebreltinib efficacy and safety in NSCLC patients with METex14 skipping mutations
| Autor: | Pérol, M., Awad, M., Devarakonda, S., Yang, J-J., Zhang, Y., Wu, L., Hu, J., Wang, Z., Planchard, D., Garrido Lopez, P., Lindsay, C., Moore, M., Bulotta, A., Carcereny, E., Provencio Pulla, M., Yang, J.C-H., Spigel, D.R., Nadal, E., Yu, K-H.P., Wu, Y-L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S867-S867 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|